As of close of business last night, Unitedhealth Group Inc’s stock clocked out at $458.14, down -6.44% from its previous closing price of $489.70. In other words, the price has decreased by -$31.56 from its previous closing price. On the day, 11854080 shares were traded.
Ratios:
To gain a deeper understanding of UNH’s stock, we examine its different ratios. In the meantime, Its Debt-to-Equity ratio is 0.76 whereas as Long-Term Debt/Eq ratio is at 0.70.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Barclays on March 06, 2024, initiated with a Overweight rating and assigned the stock a target price of $551.
On December 18, 2023, HSBC Securities Downgraded its rating to Reduce which previously was Hold and also lowered its target price recommendation from $550 to $480.
UBS Upgraded its Neutral to Buy on October 16, 2023, whereas the target price for the stock was revised from $520 to $640.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 08 ’24 when McSweeney Erin sold 1,236 shares for $483.48 per share. The transaction valued at 597,582 led to the insider holds 9,364 shares of the business.
ROOS THOMAS E sold 858 shares of UNH for $451,128 on Feb 23 ’24. The Chief Accounting Officer now owns 32,289 shares after completing the transaction at $525.79 per share. On Feb 16 ’24, another insider, THOMPSON BRIAN R, who serves as the CEO, UnitedHealthcare of the company, sold 28,943 shares for $521.00 each. As a result, the insider received 15,079,303 and left with 25,543 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, UNH now has a Market Capitalization of 422.37B and an Enterprise Value of 455.28B. As of this moment, Unitedhealth’s Price-to-Earnings (P/E) ratio for their current fiscal year is 19.21, and their Forward P/E ratio for the next fiscal year is 14.64. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.43. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.14 while its Price-to-Book (P/B) ratio in mrq is 4.77. Its current Enterprise Value per Revenue stands at 1.23 whereas that against EBITDA is 12.53.
Stock Price History:
Over the past 52 weeks, UNH has reached a high of $554.70, while it has fallen to a 52-week low of $445.68. The 50-Day Moving Average of the stock is 501.14, while the 200-Day Moving Average is calculated to be 508.92.
Shares Statistics:
It appears that UNH traded 4.08M shares on average per day over the past three months and 3.98M shares per day over the past ten days. A total of 924.00M shares are outstanding, with a floating share count of 920.26M. Insiders hold about 0.18% of the company’s shares, while institutions hold 90.47% stake in the company. Shares short for UNH as of Mar 15, 2024 were 7.29M with a Short Ratio of 1.79, compared to 6.34M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.79% and a Short% of Float of 0.79%.
Dividends & Splits
With its trailing 12-month dividend rate of 7.29, UNH has a forward annual dividend rate of 7.52. Against a Trailing Annual Dividend Yield of 1.49%, it implies a Forward Annual Dividend Yield of 1.53%. The stock’s 5-year Average Dividend Yield is 1.37. The current Payout Ratio is 30.55% for UNH, which recently paid a dividend on Mar 19, 2024 with an ex-dividend date of Mar 08, 2024. Stock splits for the company last occurred on May 31, 2005 when the company split stock in a 2:1 ratio.
Earnings Estimates
As of right now, 21 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of $6.67 for the current quarter, with a high estimate of $7.05 and a low estimate of $4.58, while EPS last year was $5.72. The consensus estimate for the next quarter is $6.91, with high estimates of $7.06 and low estimates of $6.43.
Analysts are recommending an EPS of between $28.18 and $27.03 for the fiscal current year, implying an average EPS of $27.77. EPS for the following year is $31.33, with 25 analysts recommending between $31.85 and $30.39.
Revenue Estimates
In the current quarter, 16 analysts expect revenue to total $99.47B. It ranges from a high estimate of $101B to a low estimate of $96.4B. As of the current estimate, Unitedhealth Group Inc’s year-ago sales were $89.78B, an estimated increase of 10.80% from the year-ago figure.
A total of 21 analysts have provided revenue estimates for UNH’s current fiscal year. The highest revenue estimate was $404.15B, while the lowest revenue estimate was $395.42B, resulting in an average revenue estimate of $401.03B. In the same quarter a year ago, actual revenue was $371.62B, up 7.90% from the average estimate. Based on 21 analysts’ estimates, the company’s revenue will be $432.11B in the next fiscal year. The high estimate is $438.52B and the low estimate is $414.1B. The average revenue growth estimate for next year is up 7.70% from the average revenue estimate for this year.
